Table 3.
Medication use outcomes at 3-month follow-up (n = 58).
| Medication Use Outcomes at 3-Month Follow-Up | n (%) |
|---|---|
| Use of BZD-related hypnotics | |
| No | 37 (63.79) |
| Yes | 21 (36.21) |
| Use of any medication or substance for sleep | |
| No | 17 (29.31) |
| Yes | 41 (70.69) |
BZD = benzodiazepine.